222 related articles for article (PubMed ID: 24902457)
21. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
[TBL] [Abstract][Full Text] [Related]
22. Use of hyperthermic intraperitoneal chemotherapy (HIPEC) in management of peritoneal carcinomatosis from colorectal origin.
Ceelen WP
Surg Technol Int; 2005; 14():125-30. PubMed ID: 16525964
[TBL] [Abstract][Full Text] [Related]
23. Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment.
Valle M; Federici O; Garofalo A
Surg Oncol Clin N Am; 2012 Oct; 21(4):515-31. PubMed ID: 23021713
[TBL] [Abstract][Full Text] [Related]
24. Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Riss S; Mohamed F; Dayal S; Cecil T; Stift A; Bachleitner-Hofmann T; Moran B
Eur J Surg Oncol; 2013 Sep; 39(9):931-7. PubMed ID: 23810280
[TBL] [Abstract][Full Text] [Related]
25. Peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian peritoneal carcinomatosis: an argued role.
Di Giorgio A; Cardi M; Sammartino P
Gynecol Oncol; 2010 Apr; 117(1):146-7. PubMed ID: 20096922
[No Abstract] [Full Text] [Related]
26. Peritoneal surface malignancies and regional treatment: a review of the literature.
Rubino MS; Abdel-Misih RZ; Bennett JJ; Petrelli NJ
Surg Oncol; 2012 Jun; 21(2):87-94. PubMed ID: 21216590
[TBL] [Abstract][Full Text] [Related]
27. Surgical treatment of patients with peritoneal surface malignancy: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Dunn D
J Wound Ostomy Continence Nurs; 2010; 37(4):379-85. PubMed ID: 20644370
[TBL] [Abstract][Full Text] [Related]
28. Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve.
Mohamed F; Moran BJ
Cancer J; 2009; 15(3):196-9. PubMed ID: 19556904
[TBL] [Abstract][Full Text] [Related]
29. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
Ann Surg; 2007 Jan; 245(1):104-9. PubMed ID: 17197972
[TBL] [Abstract][Full Text] [Related]
30. Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Iversen LH; Rasmussen PC; Laurberg S
Br J Surg; 2013 Jan; 100(2):285-92. PubMed ID: 23124619
[TBL] [Abstract][Full Text] [Related]
31. Ventricular tachycardia during hyperthermic intraperitoneal chemotherapy.
Thix CA; Königsrainer I; Kind R; Wied P; Schroeder TH
Anaesthesia; 2009 Oct; 64(10):1134-6. PubMed ID: 19735407
[TBL] [Abstract][Full Text] [Related]
32. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
[TBL] [Abstract][Full Text] [Related]
33. Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study.
D'Hondt V; Goffin F; Roca L; Dresse D; Leroy C; Kerger J; Cordier L; de Forges H; Veys I; Liberale G
Int J Gynecol Cancer; 2016 Jun; 26(5):912-7. PubMed ID: 27051055
[TBL] [Abstract][Full Text] [Related]
34. Hyperthermic intraperitoneal chemotherapy: methodology and safety considerations.
González-Moreno S; González-Bayón L; Ortega-Pérez G
Surg Oncol Clin N Am; 2012 Oct; 21(4):543-57. PubMed ID: 23021715
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic and cardiovascular problems during modified hyperthermic intraperitoneal perioperative chemotherapy.
Rankovic VI; Masirevic VP; Pavlov MJ; Ceranic MS; Milenkovic MG; Simic AP; Kecmanovic DM
Hepatogastroenterology; 2007 Mar; 54(74):364-6. PubMed ID: 17523275
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of pegylated liposomal doxorubicin administered by intraoperative hyperthermic intraperitoneal chemotherapy to patients with advanced ovarian cancer and peritoneal carcinomatosis.
Salvatorelli E; De Tursi M; Menna P; Carella C; Massari R; Colasante A; Iacobelli S; Minotti G
Drug Metab Dispos; 2012 Dec; 40(12):2365-73. PubMed ID: 22972909
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
Chua TC; Yan TD; Morris DL
J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
[TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine carcinomas: optimal surgery of peritoneal metastases (and associated intra-abdominal metastases).
Elias D; David A; Sourrouille I; Honoré C; Goéré D; Dumont F; Stoclin A; Baudin E
Surgery; 2014 Jan; 155(1):5-12. PubMed ID: 24084595
[TBL] [Abstract][Full Text] [Related]
39. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.
Chua TC; Quinn LE; Zhao J; Morris DL
J Surg Oncol; 2013 Aug; 108(2):81-8. PubMed ID: 23737041
[TBL] [Abstract][Full Text] [Related]
40. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.
Kianmanesh R; Scaringi S; Sabate JM; Castel B; Pons-Kerjean N; Coffin B; Hay JM; Flamant Y; Msika S
Ann Surg; 2007 Apr; 245(4):597-603. PubMed ID: 17414609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
